Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Up-regulation of Imp3 confers in vivo tumorigenicity on murine osteosarcoma cells.

PloS one - 1 Jan 2012

Ueki Arisa, Shimizu Takatsune, Masuda Kenta, Yamaguchi Sayaka I, Ishikawa Tomoki, Sugihara Eiji, Onishi Nobuyuki, Kuninaka Shinji, Miyoshi Keita, Muto Akihiro, Toyama Yoshiaki, Banno Kouji, Aoki Daisuke, Saya Hideyuki

Abstract excerpt

Osteosarcoma is a high-grade malignant bone tumor that manifests ingravescent clinical behavior. The intrinsic events that confer malignant properties on osteosarcoma cells have remained unclear, however. We previously established two lines of mouse osteosarcoma cells: AX cells, which are able to form tumors in syngeneic mice, and AXT cells, which were derived from such tumors and acquired an increased...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Gene Knockdown Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Osteosarcoma

Share to Phenotype

Share to RNA-Binding Proteins

Share to Up-Regulation

Source

Open in PubMed Open full text

Identifiers

PMID: 23226335
DOI: 10.1371/journal.pone.0050621
PMCID: PMC3511546

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Up-regulation of Imp3 confers in vivo tumorigenicity on murine osteosarcoma cells.PMID 23226335Read ↗

Oncofetal Protein IMP3, a New Cancer BiomarkerSemantic proximity Read ↗

EID3 Promotes Cancer Stem Cell-Like Phenotypes in Osteosarcoma through the Activation of PI3K-AKT Signaling Pathway.Semantic proximity Read ↗

Tropomodulin 3 modulates EGFR‐PI3K‐AKT signaling to drive hepatocellular carcinoma metastasisSemantic proximity Read ↗

RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma.Semantic proximity Read ↗

ANXA3 activates HIF-1α/VEGF Signaling Via the PI3K/AKT/mTOR Pathway to Promote Osteosarcoma Stem Cell-Like Phenotype.Semantic proximity Read ↗

ATIP3, a Novel Prognostic Marker of Breast Cancer Patient Survival, Limits Cancer Cell Migration and Slows Metastatic Progression by Regulating Microtubule DynamicsSemantic proximity Read ↗

Oncogenic Properties of Candidate Oncogenes in Chromosome Region 17p11.2p12 in Human OsteosarcomaSemantic proximity Read ↗

Ets2 anchors the prometastatic function of mutant p53 in osteosarcoma.Semantic proximity Read ↗

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1RSemantic proximity Read ↗

IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.Semantic proximity Read ↗

IMP3 promotes TNBC stem cell property through miRNA-34a regulation.Semantic proximity Read ↗

IGFBP-3 is a metastasis suppression gene in prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.